The Smart Way to Adopt AI in Clinical Trials and Regulatory Affairs with Keith Parent
As AI transforms clinical trials and regulatory operations, life science teams face unique challenges in adopting these technologies within GxP-regulated environments. How can companies maintain compliance while automating document processing? Where should clinical and regulatory teams begin their AI journey?
We sat down with Keith Parent, CEO of Court Square Group and RegDocs365, to explore these pressing questions. With over 30 years of experience working with pharmaceutical, biotech, and medical device companies of all sizes, Keith gives us a unique frontline look at how firms are implementing AI solutions in clinical trials and regulatory operations right now.
From automated document processing to regulatory intelligence, their discussion cuts through the hype to examine real-world applications and implementation strategies that companies can begin exploring today.